KRISTEN MALONEY: Open Payments
NPI 1346438686 · CHEEKTOWAGA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$325 in 16 payments from 9 companies in 2025. Trend: 2023 $621 · 2024 $687 · 2025 $325
Food & beverage: $325
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 4 | $92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| Boston Scientific Corporation | 2 | $32 |
| Amgen Inc. | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Abbott Laboratories | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Novo Nordisk Inc | 1 | $14 |
Products named: JARDIANCE, WATCHMAN, SAPIEN 3 Ultra RESILIA, REPATHA, AMVUTTRA, AMPLATZER AMULET, FARXIGA, LEQVIO.
Industry payments across NY — which companies pay providers there.
